产前全氟烷基物质浓度与随访7至9年时母亲β细胞功能的关系
在母婴环境化学物研究(MIREC)中,测量258名参与者妊娠中期血浆9种PFAS浓度,并在产后7至9年检测血糖稳态指标。产前全氟壬酸和全氟癸酸浓度与HOMA-IR升高相关,全氟辛酸加倍与完整胰岛素原及β细胞功能比值升高相关。作者认为产前PFAS暴露可能影响母亲长期胰岛素抵抗和β细胞功能,且关联因PFAS种类而异。
要点
- 产前全氟壬酸浓度每加倍,随访时HOMA-IR升高13.9%(95%CI:0.8,28.8)。
- 产前全氟癸酸浓度每加倍,随访时HOMA-IR升高10.5%(95%CI:-1.0,23.4)。
- 产前全氟辛酸浓度每加倍,完整胰岛素原升高12.8%(95%CI:-3.5,31.8)。
核心结论
- 产前PFAS暴露可能影响母亲长期胰岛素抵抗和β细胞功能,这两者是2型糖尿病的关键风险因素;这些关联因具体PFAS种类而异。
研究设计与样本
- 在母婴环境化学物研究(MIREC)参与者中测量妊娠中期血浆9种PFAS浓度。
- 在MIREC妊娠后7至9年采集样本(n=258),检测空腹完整胰岛素原、C肽、胰岛素、葡萄糖和血红蛋白A1C。
- 推导胰腺β细胞功能指标(胰岛素原与胰岛素比值[PI:INS]、胰岛素原与C肽比值[PI:CP])和胰岛素抵抗指标(胰岛素抵抗稳态模型评估[HOMA-IR]、甘油三酯-葡萄糖指数)。
- 采用多变量线性回归模型量化每种PFAS浓度每加倍时各结局的百分比变化。
- 使用分位数g计算和加权分位数和回归评估PFAS混合物。
主要发现
- 产前全氟壬酸浓度每加倍,HOMA-IR升高13.9%(95%CI:0.8,28.8)。
- 产前全氟癸酸浓度每加倍,HOMA-IR升高10.5%(95%CI:-1.0,23.4)。
- 产前全氟壬酸浓度每加倍,空腹胰岛素升高11.9%(95%CI:0.1,25.1)。
- 产前全氟癸酸浓度每加倍,空腹胰岛素升高8.9%(95%CI:-1.5,20.3)。
- 产前全氟辛酸浓度每加倍,完整胰岛素原升高12.8%(95%CI:-3.5,31.8),PI:INS升高11.5%(95%CI:-4.4,30.1),PI:CP升高13.5%(95%CI:-2.4,32.0)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Epidemiological evidence regarding prenatal per- and polyfluoroalkyl substance (PFAS) exposure and long-term maternal metabolic health outcomes is lacking. OBJECTIVE: Quantify associations between prenatal PFAS concentrations and maternal metabolic biomarkers of glucose homeostasis 7 to 9 years later. METHODS: We measured second trimester plasma concentrations of 9 PFAS in participants enrolled in the Maternal-Infant Research on Environmental Chemicals (MIREC) study. We measured individual biomarkers of glucose homeostasis (fasting intact proinsulin, C-peptide, insulin, glucose, and hemoglobin A1C levels) in samples collected 7 to 9 years after the MIREC pregnancy (n = 258) and derived indicators of pancreatic beta cell function (proinsulin to insulin [PI:INS], proinsulin to C-peptide [PI:CP] ratios) and insulin resistance (homeostatic model assessment for insulin resistance [HOMA-IR], triglyceride-glucose index). Using multivariable linear regression models, we quantified the percent change in each outcome per doubling of individual PFAS concentrations. We used quantile g-computation and weighted quantile sum regression to evaluate the mixture of PFAS. RESULTS: Prenatal perfluorononanoic acid and perfluorodecanoic acid concentrations were associated with 13.9% (95% CI: 0.8, 28.8) and 10.5% (95% CI: -1.0, 23.4) higher HOMA-IR values as well as 11.9% (95% CI: 0.1, 25.1) and 8.9% (95% CI: -1.5, 20.3) higher fasting insulin concentrations, respectively. A doubling of perfluorooctanoic acid concentrations was associated with increases in intact proinsulin concentrations (12.8% [95% CI: -3.5, 31.8]) and beta cell function ratios (PI:INS: 11.5% [95% CI: -4.4, 30.1]; PI:CP: 13.5% [95% CI: -2.4, 32.0]). CONCLUSION: Prenatal exposure to PFAS may impact long-term maternal insulin resistance and beta cell function, key risk factors for type 2 diabetes. These associations differ by specific PFAS.
引用
- Palaniyandi J, Bruin JE, Fisher M, et al. Prenatal Concentrations of Perfluoroalkyl Substances and Maternal Beta Cell Function at 7 to 9 Years of Follow-Up. J Clin Endocrinol Metab. 2025. PMID: 40132045. doi:10.1210/clinem/dgaf143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。